Skip to content

SION SION Market capitalization

Market capitalization at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$113.44B-8.9%
AbbVie logo
AbbVieABBV
$384.69B+3.8%
Septerna, Inc. logo
Septerna, Inc.SEPN
$1.08B+319%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$2.39B+52.3%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$3.04B+54.2%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.22B+19.9%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Enterprise value$1.74B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Computed from the period-end share price: $1.8B.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's market capitalization?
SION (SION) reported market capitalization of $1.8B in Q1 2026.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.